Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet [Procardia] — RxCUI 207772
RxNorm drug concept · Semantic branded drug
RxCUI 207772
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
5 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI207772
Official nameOsmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet [Procardia]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asProcardia 30 MG Osmotic 24 HR Extended Release Oral Tablet; Procardia XL 30 MG 24HR Extended Release Oral Tablet
FDA products mapped2
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Nifedipine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Nifedipine relaxes and widens your blood vessels. If you have high blood pressure, that widening makes it easier for your heart to pump, which brings your numbers down and lowers y...
- What exactly is nifedipine supposed to do for me?
- It depends on your form. If you're taking the extended-release tablet, a high-fat meal can noticeably increase the amount of drug that gets into your bloodstream. That doesn't mean...
- Does it matter if I take nifedipine with food?
🕸️ Concept Web — How Osmotic 24 HR nifedipine 30 MG Extended Release... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet [Procardia]
RxCUI 207772 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Nifedipine
7417IN
-
Nifedipine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Procardia
203423BN
-
Procardia
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Nifedipine Extended Release Oral Tablet
373070SCDF -
Nifedipine Oral Product
1158688SCDG -
Nifedipine Pill
1158689SCDG -
Nifedipine Extended Release Oral Tablet [Procardia]
491279SBDF -
Procardia Oral Product
1180008SBDG -
Procardia Pill
1180009SBDG -
Extended Release Oral Tablet
316945DF -
Oral Product
1151131DFG - +1 more in this family
-
Nifedipine Extended Release Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet
1812011SCD -
Nifedipine 30 MG
317655SCDC -
Nifedipine 30 MG [Procardia]
491288SBDC
-
Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet
SCD · 1812011 -
Nifedipine 30 MG
SCDC · 317655 -
Nifedipine Extended Release Oral Tablet
SCDF · 373070 -
Nifedipine Oral Product
SCDG · 1158688 -
Nifedipine Pill
SCDG · 1158689
Brand-Name Concepts
-
Nifedipine 30 MG [Procardia]
SBDC · 491288 -
Nifedipine Extended Release Oral Tablet [Procardia]
SBDF · 491279 -
Procardia Oral Product
SBDG · 1180008 -
Procardia Pill
SBDG · 1180009 -
Procardia
BN · 203423
📦 FDA Products & Package NDCs
2 products · 5 package NDCs
5 package NDCs map to RxCUI 207772 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00069-2650-41 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK... | Procardia XL | Pfizer Laboratories Div Pfizer Inc | 1989-09-06 |
| 00069-2650-66 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-... | Procardia XL | Pfizer Laboratories Div Pfizer Inc | 1989-09-06 |
| 00069-2650-72 | 300 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-... | Procardia XL | Pfizer Laboratories Div Pfizer Inc | 1989-09-06 |
| 00069-2660-41 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK... | Procardia XL | Pfizer Laboratories Div Pfizer Inc | 1989-09-06 |
| 00069-2660-66 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-... | Procardia XL | Pfizer Laboratories Div Pfizer Inc | 1989-09-06 |
Observed labelers:
Pfizer Laboratories Div Pfizer Inc (5)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.